RECOMBINANT VACCINIA IMMUNIZATION IN THE PRESENCE OF PASSIVELY ADMINISTERED ANTIBODY

被引:7
作者
JOHNSON, MP
MEITIN, CA
BENDER, BS
SMALL, PA
机构
[1] UNIV FLORIDA,COLL MED,DEPT IMMUNOL & MED MICROBIOL,POB 100266,GAINESVILLE,FL 32610
[2] VET ADM MED CTR,CTR EDUC & CLIN,GAINESVILLE,FL 32610
[3] UNIV FLORIDA,COLL MED,DEPT MED,GAINESVILLE,FL 32610
关键词
VACCINIA; RECOMBINANT; INFLUENZA; PASSIVELY ADMINISTERED ANTIBODY;
D O I
10.1016/0264-410X(93)90314-N
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mice were injected with immune serum to vaccinia and/or influenza virus and ten immunized by scarification with a recombinant vaccinia virus expressing the influenza haemagglutinin H1. The serum IgG antibody response to the foreign gene product, influenza H1, was suppressed by the passively administered anti-influenza antibody in a dose-dependent manner. Anti-vaccinia antibody alone had no effect on the anti-haemagglutinin antibody response to the recombinant vaccinia and did not suppress an anti-vaccinia antibody response. Secondary cytotoxic T-lymphocyte killing of influenza virus-infected target cells was relatively low in all animals that were immunized with the recombinant vaccinia, and showed some dose-dependent suppression by the passively administered antibody. The dose dependence of the inhibition suggests that while immunization with recombinant vaccinia viruses may not be effective at birth, they may be useful at several months of age.
引用
收藏
页码:665 / 669
页数:5
相关论文
共 29 条
[11]   MEASLES-VACCINE FAILURE - SURVEY OF CAUSES AND MEANS OF PREVENTION [J].
HAYDEN, GF .
CLINICAL PEDIATRICS, 1979, 18 (03) :155-&
[12]  
Jenner E., 1798, INQUIRY CAUSES EFFEC
[13]  
JOHNSON MP, 1988, VACCINES 88
[14]   ACCIDENTAL HUMAN VACCINATION WITH VACCINIA VIRUS EXPRESSING NUCLEOPROTEIN GENE [J].
JONES, L ;
RISTOW, S ;
YILMA, T ;
MOSS, B .
NATURE, 1986, 319 (6054) :543-543
[15]  
MOSS B, 1987, ANNU REV IMMUNOL, V5, P305, DOI 10.1146/annurev.iy.05.040187.001513
[16]   PASSIVE TRANSFER OF RESPIRATORY SYNCYTIAL VIRUS (RSV) ANTISERUM SUPPRESSES THE IMMUNE-RESPONSE TO THE RSV FUSION (F) AND LARGE (G) GLYCOPROTEINS EXPRESSED BY RECOMBINANT VACCINIA VIRUSES [J].
MURPHY, BR ;
OLMSTED, RA ;
COLLINS, PL ;
CHANOCK, RM ;
PRINCE, GA .
JOURNAL OF VIROLOGY, 1988, 62 (10) :3907-3910
[17]  
MURPHY BR, 1989, J GEN VIROL, V72, P2185
[18]   CONSTRUCTION OF LIVE VACCINES USING GENETICALLY ENGINEERED POXVIRUSES - BIOLOGICAL-ACTIVITY OF VACCINIA VIRUS RECOMBINANTS EXPRESSING THE HEPATITIS-B VIRUS SURFACE-ANTIGEN AND THE HERPES-SIMPLEX VIRUS GLYCOPROTEIN-D [J].
PAOLETTI, E ;
LIPINSKAS, BR ;
SAMSONOFF, C ;
MERCER, S ;
PANICALI, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (01) :193-197
[19]   RECOMBINANT VACCINIA VIRUS - IMMUNIZATION AGAINST MULTIPLE PATHOGENS [J].
PERKUS, ME ;
PICCINI, A ;
LIPINSKAS, BR ;
PAOLETTI, E .
SCIENCE, 1985, 229 (4717) :981-984
[20]   COMPARISON OF INACTIVATED, LIVE AND RECOMBINANT DNA VACCINES AGAINST INFLUENZA-VIRUS IN A MOUSE MODEL [J].
ROTA, PA ;
DE, BK ;
SHAW, MW ;
BLACK, RA ;
GAMBLE, WC ;
KENDAL, AP .
VIRUS RESEARCH, 1990, 16 (01) :83-94